Blue Jet Healthcare Ltd

Stage 3 · Topping · week 2

As of 16 Oct 2026, Blue Jet Healthcare is in Stage 3 — topping, where an uptrend loses steam, in week 2 (since 5 Oct 2026). It closed at ₹521, 23.2% below its 52-week high and above its 200-day average, which is falling. In Health Care, 40.6% of stocks are in Stage 2.

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. More about the company

₹520.7
+0.23% today
₹9,031 Cr · Mid cap
Market Neutral — FadingHealth Care 40.6% in Stage 2-7.4 pts / 20dPharmaceuticals 50.4%-2.5 pts

Pro read

Pro

Our read

Topping — the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is BLUEJET early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-23.2%
₹327.3 lo₹677.8 hi
23.2% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 2
1w13w26w
Week 2 — early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
6.3%
200 DMA: ₹489.8 · sloping down
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.28x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↓
MA20 rolling over · -4.0% vs MA50 -3.2%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-7.9%
3M
-10.9%
6M
+24.9%
YTD
-6.0%
1Y
-21.5%
Sector
Health Care
↓ Peaking
Stage 2%
40.6%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
Sector has 67 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
↓ Peaking
Stage 2%
50.4%
20d Δ
-2.5pp
1M return
-2.3%
3M return
-0.6%
Industry Stage-2 % · last 20 days
Industry has 57 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Stage Cycle Timeline2023-11-01 → 2026-10-16
S? 43w
S2 36w
S4 32w
2023-11-012026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 43w → S2 36w → S3 3w → S2 11w → S3 6w → S4 32w → S1 10w → S2 11w → S3 2w current
Total tracked: 153 weeks across 9 stage runs.
Scan Membership
Prop Scan
Latest: 2026-09-01
Pullback Hunter
Latest: 2026-08-21
Breakout Watch
Latest: 2026-07-15
30 appearances in last 60 days. First seen: 2024-08-27.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding — staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-16S3
Wk 2 · Vol 0.28x
2026-10-15S3
Wk 2 · Vol 0.39x
2026-10-14S3
Wk 2 · Vol 0.39x
2026-10-13S3
Wk 2 · Vol 0.43x
2026-10-12S3
Wk 2 · Vol 0.22x
2026-10-09S3
Wk 1 · Vol 0.26x
2026-10-08S3
Wk 1 · Vol 0.44x
2026-10-07S3
Wk 1 · Vol 0.28x
2026-10-06S3
Wk 1 · Vol 0.39x
2026-10-05S32→3
Wk 1 · Vol 0.40x
2026-10-01S2
Wk 12 · Vol 0.70x
2026-09-30S2
Wk 11 · Vol 0.53x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹567.9
200 DMA
₹489.8
52W High
₹677.8
52W Low
₹327.3
5D Low
₹517.9
Resistance levels (recent highs)
20d High
₹587.3
60d High
₹626.3
120d High
₹626.3
250d High
₹674.1
Next resistance
+12.8%
to 20d High
Ask the Market AI about BLUEJETAsk →
P/E (TTM)
32.9
Forward 24.6
Earnings Growth (YoY)
-41.5%
Revenue -24.3%
ROE
+19.9%
Profit margin +24.4%
Dividend Yield
0.24%
P/B 6.0
About this companyHealth Care· Pharmaceuticals

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.